Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

NCT00414076 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Leiomyosarcoma
Uterine Neoplasm

Interventions

DRUG: Letrozole

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]